Literature DB >> 10642243

Meningococcal disease in healthcare workers. Vaccine is available in Latin America.

C Trujillo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10642243      PMCID： PMC1117442     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Nosocomial meningococcemia in a physician.

Authors:  J F Gehanno; L Kohen-Couderc; J F Lemeland; J Leroy
Journal:  Infect Control Hosp Epidemiol       Date:  1999-08       Impact factor: 3.254

2.  Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.

Authors:  J W Tappero; R Lagos; A M Ballesteros; B Plikaytis; D Williams; J Dykes; L L Gheesling; G M Carlone; E A Høiby; J Holst; H Nøkleby; E Rosenqvist; G Sierra; C Campa; F Sotolongo; J Vega; J Garcia; P Herrera; J T Poolman; B A Perkins
Journal:  JAMA       Date:  1999-04-28       Impact factor: 56.272

3.  Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-02-14

4.  Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland.

Authors:  B A Perkins; K Jonsdottir; H Briem; E Griffiths; B D Plikaytis; E A Hoiby; E Rosenqvist; J Holst; H Nokleby; F Sotolongo; G Sierra; H C Campa; G M Carlone; D Williams; J Dykes; D Kapczynski; E Tikhomirov; J D Wenger; C V Broome
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

5.  Secondary prevention of meningococcal disease.

Authors:  B E Kristiansen; A B Knapskog
Journal:  BMJ       Date:  1996-03-09

6.  Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis.

Authors:  P Yagupsky; S Ashkenazi; C Block
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

7.  Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil.

Authors:  J C de Moraes; B A Perkins; M C Camargo; N T Hidalgo; H A Barbosa; C T Sacchi; I M Landgraf; V L Gattas; H de G Vasconcelos; I M Gral
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

8.  Effect of cefotaxime or ceftriaxone treatment on nasopharyngeal Haemophilus influenzae type b colonization in children.

Authors:  P N Goldwater
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

9.  Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

Authors:  C P Noronha; C J Struchiner; M E Halloran
Journal:  Int J Epidemiol       Date:  1995-10       Impact factor: 7.196

10.  Control of meningococcal disease: guidance for consultants in communicable disease control. PHLS Meningococcal Infections Working Group and Public Health Medicine Environmental Group.

Authors: 
Journal:  Commun Dis Rep CDR Rev       Date:  1995-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.